NCT00776139View on ClinicalTrials.gov

Bioequivalence Study of Cetirizine Hydrochloride 10mg Tablets Under Fasting Conditions

NACompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

October 31, 2004

Study Completion Date

December 31, 2004

Conditions
Healthy
Interventions
DRUG

Cetirizine Hydrochloride 10 mg tablet

Bioequivalence Cetirizine Hydrochloride 10 mg tablet

Trial Locations (1)

21201

Bioanalytical Systems, Inc., Baltimore

All Listed Sponsors
lead

Ranbaxy Laboratories Limited

INDUSTRY

NCT00776139 - Bioequivalence Study of Cetirizine Hydrochloride 10mg Tablets Under Fasting Conditions | Biotech Hunter | Biotech Hunter